NYSE:OSTX OS Therapies (OSTX) Stock Price, News & Analysis $2.14 +0.08 (+3.88%) (As of 11/29/2024 04:45 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends About OS Therapies Stock (NYSE:OSTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OS Therapies alerts:Sign Up Key Stats Today's Range$1.93▼$2.2050-Day Range$1.74▼$3.2852-Week Range$1.58▼$4.90Volume5,916 shsAverage Volume24,205 shsMarket Capitalization$45.45 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingStrong Buy Company OverviewOS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.Read More… Urgent Briefing: Why Wyoming is vital for a 2025 AI portfolio (Ad)We have a truly special way for you to gain access to all this information. For one day only … this Black Friday (Cyber Monday) … we are offering an opportunity to score access to this wealth of information … for just $19.You read that correctly — just $19. This offer is limited to Black Friday (Cyber Monday) ONLY Receive OSTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OS Therapies and its competitors with MarketBeat's FREE daily newsletter. Email Address OSTX Stock News HeadlinesOS Therapies (NYSE:OSTX) Now Covered by Maxim GroupNovember 27, 2024 | americanbankingnews.comMaxim Group Initiates Coverage of OS Therapies (OSTX) with Buy RecommendationNovember 27, 2024 | msn.comUrgent Briefing: Why Wyoming is vital for a 2025 AI portfolioWe have a truly special way for you to gain access to all this information. For one day only … this Black Friday (Cyber Monday) … we are offering an opportunity to score access to this wealth of information … for just $19.December 1, 2024 | Weiss Ratings (Ad)OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 15, 2024 | businesswire.comOSTX Stock Earnings: OS Therapies Reported Results for Q2 2024November 15, 2024 | investorplace.comOSTX Stock Earnings: OS Therapies Reported Results for Q2 2024November 12, 2024 | investorplace.comOSTX Stock Earnings: OS Therapies Reported Results for Q2 2024November 11, 2024 | investorplace.comOS Therapies to Present at The Spartan Capital Investor ConferenceNovember 5, 2024 | finance.yahoo.comSee More Headlines OSTX Stock Analysis - Frequently Asked Questions How have OSTX shares performed this year? OS Therapies' stock was trading at $4.00 at the start of the year. Since then, OSTX shares have decreased by 46.5% and is now trading at $2.14. View the best growth stocks for 2024 here. When did OS Therapies IPO? OS Therapies (OSTX) raised $8 million in an initial public offering on Thursday, August 1st 2024. The company issued 2,000,000 shares at $4.00 per share. Brookline Capital Markets (Division of Arcadia Securities LLC) acted as the underwriter for the IPO. When does OS Therapies' lock-up period expire? OS Therapies' lock-up period expires on Tuesday, January 28th. OS Therapies had issued 1,600,000 shares in its initial public offering on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period. Who are OS Therapies' major shareholders? OS Therapies' top institutional shareholders include Virtu Financial LLC (0.05%). How do I buy shares of OS Therapies? Shares of OSTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of OS Therapies own? Based on aggregate information from My MarketBeat watchlists, some other companies that OS Therapies investors own include AST SpaceMobile (ASTS), Energy Transfer (ET), Black Stone Minerals (BSM), Kinder Morgan (KMI), Main Street Capital (MAIN), Atlas Energy Solutions (AESI) and Chevron (CVX). Company Calendar Today11/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNYSE:OSTX Previous SymbolNYSE:OSTX CUSIPN/A CIK1795091 WebN/A Phone(410) 297-7793FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+273.8%Consensus RatingStrong Buy Rating Score (0-4)3.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,790,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-569.57% Debt Debt-to-Equity RatioN/A Current Ratio0.76 Quick Ratio0.76 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-71.33Miscellaneous Outstanding Shares21,238,000Free FloatN/AMarket Cap$45.45 million OptionableN/A BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (NYSE:OSTX) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredThe Trump Surge-SectorsIt's already responsible for the greatest stock market achievements in history. It predicted President Trump's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OS Therapies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share OS Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
